Daybue 200 mg/mL
trofinetide · SOLUTION · Acadia Pharmaceuticals Inc.
Daybue (trofinetide) is an oral solution used to treat Rett syndrome, a rare genetic neurological disorder that affects brain development. This medication works by inhibiting a specific enzyme involved in drug metabolism in the body.
Key Facts
- Brand Name
- Daybue
- Generic Name
- trofinetide
- NDC Code (Product)
63090-660- Manufacturer
- Acadia Pharmaceuticals Inc.
- Strength
- 200 mg/mL
- Dosage Form
- SOLUTION
- Route
- ORAL
- Marketing Status
- Application #
- NDA217026
- Drug Class
- Cytochrome P450 3A4 Inhibitors [MoA]; Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]
- Marketing Start
- 03/10/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is Daybue used for?
Daybue (trofinetide) is an oral solution used to treat Rett syndrome, a rare genetic neurological disorder that affects brain development. This medication works by inhibiting a specific enzyme involved in drug metabolism in the body.
Is Daybue a controlled substance?
Daybue is not classified as a controlled substance by the DEA.
What is the generic name for Daybue?
The generic name for Daybue is trofinetide. There are 3 other brand versions of trofinetide.
What is the NDC code for Daybue 200 mg/mL?
The NDC (National Drug Code) for Daybue 200 mg/mL is 63090-660, listed by Acadia Pharmaceuticals Inc..